TILVESTAMAB
UNII IZK2TH7X5M

Substance Identification & Data

This profile provides standardized clinical and technical data for Tilvestamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) IZK2TH7X5M.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2226775-26-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

IZK2TH7X5M

CAS Registry Number

2226775-26-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TILVESTAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175866

National Cancer Institute reference terminology for clinical and research data.

INN ID

11122

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tilvestamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TILVESTAMAB

Common Names & Synonyms

HUMANISED IGG1 ANTI-AXL MONOCLONAL ANTIBODY BGB149

IMMUNOGLOBULIN IGG1, ANTI-(HUMAN RECEPTOR TYROSINE KINASE AXL) (HUMAN-MUS MUSCULUS MONOCLONAL BGB149 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BGB149 .KAPPA.-CHAIN, DIMER

TILVESTAMAB [INN]

TILVESTAMAB [WHO-DD]